| Purification and characterization of naturally occurring HIV-1 (South African subtype C) protease mutants from inclusion bodies SB Maseko, S Natarajan, V Sharma, N Bhattacharyya, T Govender, ... Protein expression and purification 122, 90-96, 2016 | 31 | 2016 |
| A proteome-scale map of the SARS-CoV-2–human contactome DK Kim, B Weller, CW Lin, D Sheykhkarimli, JJ Knapp, G Dugied, ... Nature Biotechnology 41 (1), 140-149, 2023 | 29 | 2023 |
| The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape C Vandermeulen, T O’grady, J Wayet, B Galvan, S Maseko, M Cherkaoui, ... PLoS pathogens 17 (9), e1009919, 2021 | 25 | 2021 |
| Purification and Characterization of Exo-Inulinase from Paenibacillus sp. d9 Strain S Jeza, SB Maseko, J Lin The protein journal 37, 70-81, 2018 | 16 | 2018 |
| Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics … VT Sabe, GF Tolufashe, CU Ibeji, SB Maseko, T Govender, GEM Maguire, ... Journal of Molecular Modeling 25, 1-16, 2019 | 15 | 2019 |
| I36T↑ T mutation in South African subtype C (C-SA) HIV-1 protease significantly alters protease-drug interactions SB Maseko, E Padayachee, T Govender, Y Sayed, G Kruger, ... Biological chemistry 398 (10), 1109-1117, 2017 | 15 | 2017 |
| Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach ZK Sanusi, T Govender, GEM Maguire, SB Maseko, J Lin, HG Kruger, ... Journal of Molecular Graphics and Modelling 76, 77-85, 2017 | 13 | 2017 |
| An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑ N↑ L PR mutant ZK Sanusi, T Govender, GEM Maguire, SB Maseko, J Lin, HG Kruger, ... Journal of Computer-Aided Molecular Design 32, 459-471, 2018 | 12 | 2018 |
| Purification and characterization of α-amylase from Paenibacillus sp. D9 and Escherichia coli recombinants K Naidu, S Maseko, G Kruger, J Lin Biocatalysis and Biotransformation 38 (1), 24-34, 2020 | 10 | 2020 |
| Optimized procedure for recovering HIV-1 protease (C-SA) from inclusion bodies SB Maseko, D Govender, T Govender, T Naicker, J Lin, GEM Maguire, ... The protein journal 38, 30-36, 2019 | 7 | 2019 |
| A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals J Olivet, SB Maseko, AN Volkov, K Salehi-Ashtiani, K Das, ... Molecular Therapy 30 (5), 1797-1800, 2022 | 6 | 2022 |
| Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D up arrow G up arrow S mutant in the South African HIV-1 subtype C protease S Maseko, E Padayachee, S Maphumulo, T Govender, Y Sayed, ... JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY 34 (1), 1451-1456, 2019 | 5* | 2019 |
| Mechanistic insight on the inhibition of D, D-carboxypeptidase from Mycobacterium tuberculosis by β-lactam antibiotics: an ONIOM acylation study T Ntombela, A Seupersad, S Maseko, CU Ibeji, G Tolufashe, ... Journal of Biomolecular Structure and Dynamics 40 (17), 7645-7655, 2022 | 4 | 2022 |
| Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA‐approved inhibitors: MD study SI Maphumulo, AK Halder, T Govender, S Maseko, GEM Maguire, ... Chemical biology & drug design 92 (5), 1899-1913, 2018 | 4 | 2018 |
| AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor P Trepte, C Secker, J Olivet, J Blavier, S Kostova, SB Maseko, I Minia, ... Molecular Systems Biology 20 (4), 428-457, 2024 | 2 | 2024 |
| Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction SB Maseko, Y Brammerloo, I Van Molle, A Sogues, C Martin, C Gorgulla, ... Antiviral research 217, 105675, 2023 | 2 | 2023 |
| Interactome and structural basis for targeting the human T-cell leukemia virus Tax oncoprotein SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, ... bioRxiv, 2021.08. 25.457680, 2021 | 1 | 2021 |
| Nanobodies against SARS-CoV-2 non-structural protein Nsp9 inhibit viral replication by targeting innate immunity T Venit, J Blavier, SB Maseko, S Shu, L Espada, C Breunig, HP Holthoff, ... bioRxiv, 2023.10. 12.561992, 2023 | | 2023 |
| A gut meta-interactome map reveals modulation of human immunity by microbiome effectors V Young, B Dohai, TCA Hitch, P Hyden, B Weller, NS Heusden, D Saha, ... bioRxiv, 2023.09. 25.559292, 2023 | | 2023 |
| AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor (preprint) P Trepte, C Secker, S Kostova, SB Maseko, SG Choi, J Blavier, I Minia, ... | | 2023 |
Thavendran GovenderUniversity of ZululandVerified email at unizulu.ac.za
